Autopsy report · NCT00779285
Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)
Cause of deathNo reason given
Life of this trial
- Registered 2 years 8 months after it had already started.
- Ran for about 6 months before it stopped.
- 1 participant enrolled.
- Results were posted on the registry 3 years 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Merck Sharp & Dohme LLC
- Sponsor type
- Industry
- Conditions
- Breast Neoplasm
- Interventions
- Pegylated Liposomal Doxorubicin
- Participants
- 1
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.